| 前收市價 | 1.7300 |
| 開市 | 1.7100 |
| 買盤 | 1.6500 x 200 |
| 賣出價 | 1.7000 x 100 |
| 今日波幅 | 1.6700 - 1.7450 |
| 52 週波幅 | 1.0400 - 2.8550 |
| 成交量 | |
| 平均成交量 | 924,009 |
| 市值 | 113.789M |
| Beta 值 (5 年，每月) | 1.02 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.0100 |
| 業績公佈日 | 2024年5月07日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 2.90 |
Insider MonkeyCytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript March 11, 2024 CytomX Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter 2023 Financial […]
ZacksCytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -50% and 13.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ZacksCytomX (CTMX) to Report Q4 Earnings: Here's What to Expect
Investor focus is likely to be on CytomX Therapeutics' (CTMX) updates on key cancer immunotherapeutic candidates, CX-904 and BMS-986288, on the fourth-quarter 2023 earnings call.
